Bibliography
- SALOMON DS, BRANDT R, CIARDIELLO F, NORMANNO N: Epidermal growth factor-related peptides and their re-ceptors in human malignancies. Grit. Rev. Oncol/Hema-tol. (1995) 19:183–232.
- SLAMON D, LEYLAND-JONES B, SHAK S et al: Addition of herceptinTM (humanized anti-HER2 antibody) to first line chemotherapy for HERZ overexpressing meta-static breast cancer (HER2+/MBC) markedly increases anticancer activity: a randomized, multinational con-trolled phase III trial. Proceedings of the Amen can Society of Clinical Oncology (1998). Abstract 377.
- PAWSON T: Protein modules and signalling networks. Nature (1995) 373:573–580.
- BASELGA J, MENDELSOHN J: Receptor blockade with monoclonal antibodies as anti-cancer therapy. Phar-macol. Therap. (1994) 64(1):127–154.
- LUETTEKE NC, PHILLIPS HK, QIU TH et al.: The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase. Genes Dev. (1994) 8:399–413.